Abstract
Purpose
The Ewing sarcoma family of tumors (EFT) is characterized by fusions of the EWSR1 gene on chromosome 22q12 with either one of the genes encoding members of the ETS family of transcription factors, in the majority of cases FLI1 or ERG. Many alternative EWSR1-ETS gene fusions have been encountered, due to variations in the locations of the EWSR1 and ETS genomic breakpoints. The resulting heterogeneity in EWSR1-ETS fusion transcripts may further be increased by the occurrence of multiple splice variants within the same tumor. Here we present a retrospective study designed to detect all of the EWSR1-FLI1 and EWSR1-ERG fusion transcripts in a series of 23 fresh frozen EFT tissues.
Methods
RT-PCR and nested fluorescent multiplex PCR were used to amplify EWSR1-FLI1 and EWSR1-ERG transcripts from EFT tissues. Fusion transcripts were identified by laser-induced fluorescent capillary electrophoresis and confirmed by sequence analysis.
Results
Nine different EWSR1-FLI1 fusion transcripts and one EWSR1-ERG fusion transcript were identified in 21 out of 23 fresh frozen EFT tissue samples. In five cases multiple fusion transcripts were found to coexist in the same tumor sample. We additionally reviewed previous reports on twelve cases with multiple EWSR1-ETS fusion transcripts.
Conclusions
Alternative splicing may frequently affect the process of EFT-associated fusion gene transcription and, as such, may significantly contribute to the pathogenic role of EFT-associated chromosome translocations. In a considerable number of cases this may result in multiple splice variants within the same tumor.
Similar content being viewed by others
References
O. Delattre, J. Zucman, B. Plougastel, C. Desmaze, T. Melot, M. Peter, H. Kovar, I. Joubert, P. de Jong, G. Rouleau, A. Aurias, G. Thomas, Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359, 162–165 (1992)
P.H. Sorensen, S.L. Lessnick, D. Lopez-Terrada, X.F. Liu, T.J. Triche, C.T. Denny, A second Ewing’s sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor. ERG. Nat. Genet. 6, 146–151 (1994)
J. Zucman, T. Melot, C. Desmaze, J. Ghysdael, B. Plougastel, M. Peter, J.M. Zucker, T.J. Triche, D. Sheer, C. Turc-Carel, P. Ambros, V. Combaret, G. Lenoir, A. Aurias, G. Thomas, O. Delattre, Combinatorial generation of variable fusion proteins in the Ewing family of tumours. EMBO J. 12, 4481–4487 (1993)
J.P. Ginsberg, E. de Alava, M. Ladanyi, L.H. Wexler, H. Kovar, M. Paulussen, A. Zoubek, B. Dockhorn-Dworniczak, H. Juergens, J.S. Wunder, I.L. Andrulis, R. Malik, P.H. Sorensen, R.B. Womer, F.G. Barr, EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing’s sarcoma. J. Clin. Oncol. 17, 1809–1814 (1999)
M.C. Le Deley, O. Delattre, K.L. Schaefer, S.A. Burchill, G. Koehler, P.C. Hogendoorn, T. Lion, C. Poremba, J. Marandet, S. Ballet, G. Pierron, S.C. Brownhill, M. Nesslböck, A. Ranft, U. Dirksen, O. Oberlin, I.J. Lewis, A.W. Craft, H. Jürgens, H. Kovar, Impact of EWS-ETS fusion type on disease progression in Ewing’s sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-E.W.I.N.G. 99 trial. J. Clin. Oncol. 28, 1982–1988 (2010)
C. Turc-Carel, A. Aurias, F. Mugneret, S. Lizard, I. Sidaner, C. Volk, J.P. Thiery, S. Olschwang, I. Philip, M.P. Berger, T. Philip, G.M. Lenoir, A. Mazabraud, Chromosomes in Ewing’s sarcoma. I. An evaluation of 85 cases of remarkable consistency of t(11;22)(q24;q12). Cancer Genet. Cytogenet. 32, 229–238 (1988)
J.R. Downing, D.R. Head, D.M. Parham, E.C. Douglass, M.G. Hulshof, M.P. Link, T.A. Motroni, H.E. Grier, A.M. Curcio-Brint, D.N. Shapiro, Detection of the (11;22)(q24;q12) translocation of Ewing’s sarcoma and peripheral neuroectodermal tumor by reverse transcription polymerase chain reaction. Am. J. Pathol. 143, 1294–1300 (1993)
I.S. Jeon, J.N. Davis, B.S. Braun, J.E. Sublett, M.F. Roussel, C.T. Denny, D.N. Shapiro, A variant Ewing’s sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Oncogene 10, 1229–1234 (1995)
F. Urano, A. Umezawa, W. Hong, H. Kikuchi, J. Hata, A novel chimera gene between EWS and E1A-F, encoding the adenovirus E1A enhancer-binding protein, in extraosseous Ewing’s sarcoma. Biochem. Biophys. Res. Commun. 219, 608–612 (1996)
M. Peter, J. Couturier, H. Pacquement, J. Michon, G. Thomas, H. Magdelenat, O. Delattre, A new member of the ETS family fused to EWS in Ewing tumors. Oncogene 14, 1159–1164 (1997)
D.C. Shing, D.J. McMullan, P. Roberts, K. Smith, S.F. Chin, J. Nicholson, R.M. Tillman, P. Ramani, C. Cullinane, N. Coleman, FUS/ERG gene fusions in Ewing’s tumors. Cancer Res. 63, 4568–4576 (2003)
T.L. Ng, M.J. O’Sullivan, C.J. Pallen, M. Hayes, P.W. Clarkson, M. Winstanley, P.H. Sorensen, T.O. Nielsen, D.E. Horsman, Ewing sarcoma with novel translocation t(2;16) producing an in-frame fusion of FUS and FEV. J. Mol. Diagn. 9, 459–463 (2007)
T. Mastrangelo, P. Modena, S. Tornielli, F. Bullrich, M.A. Testi, A. Mezzelani, P. Radice, A. Azzarelli, S. Pilotti, C.M. Croce, M.A. Pierotti, G. Sozzi, A novel zinc finger gene is fused to EWS in small round cell tumor. Oncogene 19, 3799–3804 (2000)
L. Wang, R. Bhargava, T. Zheng, L. Wexler, M.H. Collins, D. Roulston, M. Ladanyi, Undifferentiated small round cell sarcomas with rare EWS gene fusions: identification of a novel EWS-SP3 fusion and of additional cases with the EWS-ETV1 and EWS-FEV fusions. J. Mol. Diagn. 9, 498–509 (2007)
K. Szuhai, M. Ijszenga, D. de Jong, A. Karseladze, H.J. Tanke, P.C. Hogendoorn, The NFATc2 gene is involved in a novel cloned translocation in a Ewing sarcoma variant that couples its function in immunology to oncology. Clin. Cancer Res. 15, 2259–2268 (2009)
J. Sumegi, J. Nishio, M. Nelson, R.W. Frayer, D. Perry, J.A. Bridge, A novel t(4;22)(q31;q12) produces an EWSR1-SMARCA5 fusion in extraskeletal Ewing sarcoma/primitive neuroectodermal tumor. Mod. Pathol. 24, 333–342 (2011)
A. Zoubek, C. Pfleiderer, M. Salzer-Kuntschik, G. Amann, R. Windhager, F.M. Fink, E. Koscielniak, O. Delattre, S. Strehl, P.F. Ambros, H. Gadner, H. Kovar, Variability of EWS chimaeric transcripts in Ewing tumours: a comparison of clinical and molecular data. Br. J. Cancer 70, 908–913 (1994)
G. Gamberi, S. Cocchi, S. Benini, G. Magagnoli, L. Morandi, J. Kreshak, M. Gambarotti, P. Picci, L. Zanella, M. Alberghini, Molecular diagnosis in Ewing family tumors: the Rizzoli experience–222 consecutive cases in four years. J. Mol. Diagn. 13, 313–324 (2011)
A. Zoubek, B. Dockhorn-Dworniczak, O. Delattre, H. Christiansen, F. Niggli, I. Gatterer-Menz, T.L. Smith, H. Jürgens, H. Gadner, H. Kovar, Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? J. Clin. Oncol. 14, 1245–1251 (1996)
W.A. May, S.L. Lessnick, B.S. Braun, M. Klemsz, B.C. Lewis, L.B. Lunsford, R. Hromas, C.T. Denny, The Ewing’s sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1. Mol. Cell. Biol. 13, 7393–7398 (1993)
W.A. May, M.L. Gishizky, S.L. Lessnick, L.B. Lunsford, B.C. Lewis, O. Delattre, J. Zucman, G. Thomas, C.T. Denny, Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. Proc. Natl. Acad. Sci. U. S. A. 90, 5752–5756 (1993)
B. Patócs, K. Németh, M. Garami, G. Arató, I. Kovalszky, M. Szendrői, G. Fekete, Utilization of fluorescent multiplex PCR and laser-induced capillary electrophoresis for the diagnosis of Ewing family of tumours in formalin-fixed paraffin-embedded tissues. J. Clin. Path. 65, 1112–1118 (2012)
S. Ushigome, R. Machinami, P.H. Sorensen, Ewing Sarcoma/Primitive Neuroectodermal Tumour (PNET), in World Health Organisation Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone, ed. by C.D.M. Fletcher, K.K. Unni, F. Mertens (IARC Press, Lyon, 2002), pp. 297–300
M. Giovannini, J.A. Biegel, M. Serra, J.Y. Wang, Y.H. Wei, L. Nycum, B.S. Emanuel, G.A. Evans, EWS-erg and EWS-Fli1 fusion transcripts in Ewing’s sarcoma and primitive neuroectodermal tumors with variant translocations. J. Clin. Invest. 94, 489–496 (1994)
J. Zucman-Rossi, P. Legoix, J.M. Victor, B. Lopez, G. Thomas, Chromosome translocation based on illegitimate recombination in human tumors. Proc. Natl. Acad. Sci. U. S. A 95, 11786–11791 (1998)
J. Liu, M.M. Nau, J.C. Yeh, C.J. Allegra, E. Chu, J.J. Wright, Molecular heterogeneity and function of EWS-WT1 fusion transcripts in desmoplastic small round cell tumors. Clin. Cancer Res. 6, 3522–3529 (2000)
K. Yang, W.O. Lui, Y. Xie, A. Zhang, B. Skytting, N. Mandahl, C. Larsson, O. Larsson, Co-existence of SYT-SSX1 and SYT-SSX2 fusions in synovial sarcomas. Oncogene 21, 4181–4190 (2002)
W.L. Wang, E. Mayordomo, W. Zhang, V.S. Hernandez, D. Tuvin, L. Garcia, D.C. Lev, A.J. Lazar, D. López-Terrada, Detection and characterization of EWSR1/ATF1 and EWSR1/CREB1 chimeric transcripts in clear cell sarcoma (melanoma of soft parts). Mod. Pathol. 22, 1201–1209 (2009)
A. Jakubauskas, V. Valceckiene, K. Andrekute, D. Seinin, A. Kanopka, L. Griskevicius, Discovery of two novel EWSR1/ATF1 transcripts in four chimerical transcripts-expressing clear cell sarcoma and their quantitative evaluation. Exp. Mol. Pathol. 90, 194–200 (2011)
E. De Braekeleer, N. Douet-Guilbert, D. Rowe, N. Bown, F. Morel, C. Berthou, C. Férec, M. De Braekeleer, ABL1 fusion genes in hematological malignancies: a review. Eur. J. Haematol. 86, 361–371 (2011)
P.P. Pandolfi, M. Alcalay, M. Fagioli, D. Zangrilli, A. Mencarelli, D. Diverio, A. Biondi, F. Lo Coco, A. Rambaldi, F. Grignani, C. Rochette-Egly, M.P. Gaube, P. Chambon, P.G. Pelicci, Genomic variability and alternative splicing generate multiple PML/RAR alpha transcripts that encode aberrant PML proteins and PML/RAR alpha isoforms in acute promyelocytic leukaemia. EMBO J. 11, 1397–1407 (1992)
E. de Alava, A. Kawai, J.H. Healey, I. Fligman, P.A. Meyers, A.G. Huvos, W.L. Gerald, S.C. Jhanwar, P. Argani, C.R. Antonescu, F.J. Pardo-Mindan, J. Ginsberg, R. Womer, E.R. Lawlor, J. Wunder, I. Andrulis, P.H. Sorensen, F.G. Barr, M. Ladanyi, EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing’s sarcoma. J. Clin. Oncol. 16, 1248–1255 (1998)
N. Yoshino, T. Kojima, S. Asami, S. Motohashi, Y. Yoshida, M. Chin, H. Shichino, Y. Yoshida, N. Nemoto, M. Kaneko, H. Mugishima, T. Suzuki, Diagnostic significance and clinical applications of chimeric genes in Ewing’s sarcoma. Biol. Pharm. Bull. 26, 585–588 (2003)
F. Minoletti, G. Sozzi, S. Tornielli, S. Pilotti, A. Azzarelli, M.A. Pierotti, P. Radice, A novel EWS-ERG rearrangement generating two hybrid mRNAs in a peripheral primitive neuroectodermal tumour (pPNET) with a t(15;22) translocation. J. Pathol. 186, 434–437 (1998)
S.S. Bielack, M. Paulussen, G. Köhler, A patient with two Ewing’s sarcomas with distinct EWS fusion transcripts. N. Engl. J. Med. 350, 1364–1365 (2004)
T.B. Lewis, C.M. Coffin, P.S. Bernard, Differentiating Ewing’s sarcoma from other round blue cell tumors using a RT-PCR translocation panel on formalin-fixed paraffin-embedded tissues. Mod. Pathol. 20, 397–404 (2007)
R.I. Skotheim, M. Nees, Alternative splicing in cancer: noise, functional, or systematic? Int. J. Biochem. Cell Biol. 39, 1432–1449 (2007)
M. Roy, Q. Xu, C. Lee, Evidence that public database records for many cancer-associated genes reflect a splice form found in tumors and lack normal splice forms. Nucleic Acids Res. 33, 5026–5033 (2005)
Acknowledgments
The authors would like to thank Prof. Dezső Schuler for critical reading of the manuscript, Tibor Fülep and Dr. Ilona Milánkovics for their helpful suggestions and Krisztina Staub and Zsoltné Vincze for their technical assistance.
Disclosure/Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Patócs, B., Németh, K., Garami, M. et al. Multiple splice variants of EWSR1-ETS fusion transcripts co-existing in the Ewing sarcoma family of tumors. Cell Oncol. 36, 191–200 (2013). https://doi.org/10.1007/s13402-013-0126-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13402-013-0126-8